Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

Size: px
Start display at page:

Download "Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012"

Transcription

1 Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

2 Version Control This is a controlled document please destroy all previous versions on receipt of a new version. Date Approved: June 2012 Review Date: June 2014 Version Date Issued Review Date Brief Summary of Change Owner s Name Draft 1.1 October 2008 May 2009 Original guideline Network Imaging Group Draft 1.2 May 2009 November 2009 Update formatting, bring into updated Network Guidelines Network Imaging Group 1.2 November 2009 October 2010 Added Liver / Gallbladder sections Network Imaging Group 1.3 October 2010 June 2012 Reviewed with guidelines Upper GI NSSG no changes 1.4 June 2012 With Network Guidelines Reviewed with Network Guidelines October February 2012 Upper GI CEG For the latest version of these guidelines please see the NEYHCA (Cancer) website Please press control and click on the link below: Signature Sheet Agreement of the NEYHCA (Cancer) Upper GI CEG Imaging Guidelines These guidelines have been agreed by: Title Name Date Agreed Chair of the Upper GI CEG Dr Sam Khulusi Mr Prashant Jain MDT Leads Mr Kevin Wedgwood Mr Mike Tilston Dr Mohan Hingorani Chair of the NEYHCA (Cancer) Dr Ged Avery Imaging Clinical Expert Group Chair, NEYHCA Board / NEYHCA Cancer Management Group Mrs Allison Cooke The Upper GI CEG have agreed these guidelines Page 2 Upper GI CEG Imaging Guidelines Version 1.4 June 2012

3 Contents Version Control... 2 Signature Sheet... 2 Contents Introduction Oesophagus Staging of oesophageal cancer (including GOJ tumours) CT scan protocol Endoscopic Ultrasound PET-CT Laparoscopy Initial Management Restaging High grade dysplasia in Barrett s oesophagitis Follow up Stomach Staging of gastric cancer CT scan protocol Laparoscopy Re-staging Follow up GIST tumours Pancreas Staging of pancreatic cancer CT scan protocol Endoscopic ultrasound MRI PET-CT Follow up Liver Staging of malignant liver lesions CT scan protocol MRI scan PET CT Follow up Gallbladder Staging of gallbladder carcinoma CT scan protocol MRI scan PET-CT Follow up... 9 Upper GI CEG Imaging Guidelines Version 1.4 June 2012 Page 3

4 1. Introduction A Guideline is not a rigid constraint upon clinical practice, but a concept of good practice against which the requirements of the individual patient can be considered. (RCR, 1990). It therefore remains the responsibility of the practising Clinicians to interpret the application of guidelines, taking into account local service constraints and the needs and wishes of the patients. This Guidance is based on the recommendations contained in 1. A Policy Framework for Commissioning Cancer Services: Calman Hine Report published April The Royal College of Radiologists Recommendations for Cross-Sectional Imaging in Cancer Management, Issue 2 published August It is not intended to be prescriptive nor exhaustive, but a guide towards best practice. Imaging protocols may vary depending on local circumstances, and the quality of the imaging service should be supported by regular audit and by attendance at multidisciplinary meetings. Services should be planned to minimise travelling times whilst maintaining the highest standards of specialist care using local expertise and agreed protocols (Calman Hine report, paragraph 4.1.4). Patients should be scanned locally where there is suitable equipment and expertise. All clinical trials should be approved at the Upper GI CEG and if a patient is within a clinical trial which requires a change to the routine performance of the investigation or the scan to be reported against specific criteria it is the responsibility of the clinician leading the trial to discuss and agree the scanning protocols (including frequency, techniques, coverage and reporting) with the appropriate department prior to the trial commencing. 2. Oesophagus The diagnosis of oesophageal cancer is essentially made at endoscopy and confirmed by histology. If malignancy is suspected by other imaging modalities such as barium studies, this needs to be confirmed by endoscopy and histology. 2.1 Staging of oesophageal cancer (including GOJ tumours) The initial modality of staging is with CT scan to assess local disease and distant metastases. Local staging of oesophageal cancer is done by endoscopic ultrasound on patients who have resectable non-metastatic disease on CT. PET-CT scan is used as an adjunct for primary staging to assess for metastatic disease in patients considered for curative surgery. Page 4 Upper GI CEG Imaging Guidelines Version 1.4 June 2012

5 2.1.1 CT scan protocol CT of the thorax, abdomen and pelvis is performed. For tumours of the upper oesophagus, the neck is also included. Oral administration of 1 litre of water or diluted iodinated contrast medium with 400ml to be drunk immediately before going on the scanner to ensure maximum oesophagogastric distension ml of intravenous iodinated contrast medium injected at 3-4ml/sec. MDCT is commenced at 20-25sec (neck where applicable and chest) and 60-80seconds (abdomen and pelvis). Slice thickness are acquired and reformatted at mm Endoscopic Ultrasound All patients deemed fit for surgery and with no evidence of metastatic disease should undergo endoscopic ultrasound for local staging PET-CT All patients deemed fit for surgery and with no metastatic disease on CT or endoscopic ultrasound should undergo PET / CT for distant staging Laparoscopy Patients who have a significant gastric component should be considered for laparoscopy to exclude omental / peritoneal disease. 2.2 Initial Management The majority of patients receive neo-adjuvant chemotherapy / radiotherapy followed by surgery. 2.3 Restaging Restaging by CT and endoscopic ultrasound is performed to assess response to neoadjuvant therapy and to ensure lack of progression. 2.4 High grade dysplasia in Barrett s oesophagitis All patients considered for surgery should undergo similar initial staging with CT and endoscopic ultrasound. PET-CT not considered useful in this setting. The majority of patients undergo surgery as primary treatment. 2.5 Follow up Routine imaging is not considered essential following surgical resection. If resection is complete and no further treatment is considered necessary, then routine follow up imaging is not essential. Further follow up imaging is considered only if there is clinical suspicion of recurrence. If there is incomplete resection (R1) and further treatment is planned, then a baseline CT scan prior to commencement of chemotherapy/radiotherapy may be useful. Upper GI CEG Imaging Guidelines Version 1.4 June 2012 Page 5

6 If palliative chemotherapy / radiotherapy is considered due to locally advanced or metastatic disease, follow up is performed by CT scan at a frequency corresponding to the chemotherapy regime which is decided at the MDT. Patients who have radical Chemo/Radiotherapy should be considered for a repeat EUS +/- biopsy at 3 to 6 months post treatment. These patients need to be discussed at the MDT. CT scan is not considered useful in this circumstance for assessment of complete response. 3. Stomach The diagnosis of stomach cancer is essentially made at endoscopy and confirmed by histology. If malignancy is suspected by other imaging modalities such as barium studies, this needs to be confirmed by endoscopy and histology. 3.1 Staging of gastric cancer The initial modality of staging is with CT scan to assess local disease and distant metastases. Local staging of primary gastric cancer by Endoscopic ultrasound is not considered essential. PET-CT scan is not considered useful in this setting CT scan protocol CT of the thorax, abdomen and pelvis is performed. Oral administration of 1 litre of water or diluted iodinated contrast medium with 400ml to be drunk immediately before going on the scanner to ensure maximum gastric distension ml of intravenous iodinated contrast medium injected at 3-4ml/sec. MDCT is commenced at 20-25sec (chest) and 60-80seconds (abdomen and pelvis). Slice thickness are acquired at mm Laparoscopy Patients who have do not have metastatic disease on CT should have laparoscopy to detect subtle peritoneal disease. 3.2 Re-staging Patients who receive neo-adjuvant chemotherapy need a follow up CT scan prior to surgery. 3.3 Follow up Routine imaging is not considered essential following surgical resection. If resection is complete and no further treatment is considered necessary, then routine follow up imaging is not essential. Further follow up imaging is considered only if there is clinical suspicion of recurrence. If there is incomplete resection (R1) and further treatment is planned, then a baseline CT scan prior to commencement of chemotherapy / radiotherapy may be useful. If palliative chemotherapy / radiotherapy is considered due to locally advanced or metastatic disease, follow up is performed by CT scan at a frequency corresponding to the chemotherapy regime which is decided at the MDT. Page 6 Upper GI CEG Imaging Guidelines Version 1.4 June 2012

7 Patients who have radical Chemotherapy / Radiotherapy should be considered for a repeat EUS +/- biopsy at 3 to 6 months post treatment. These patients need to be discussed at the MDT. CT scan is not considered useful in this circumstance for assessment of complete response. 3.4 GIST tumours It is considered essential to perform EUS and biopsy (preferably tru-cut biopsy) to confirm submucosal gastric tumours prior to surgical removal. MDT discussion is necessary. PET/CT Scan is considered as a baseline scan if decision to treat with Glivec is made at the MDT. 4. Pancreas Ductal adenocarcinoma is the commonest type of carcinoma. Although ampullary and distal common duct carcinomas have different pathological staging, the staging workup and therapeutic options are similar. 4.1 Staging of pancreatic cancer Patients often present late with locally advanced disease. CT scan is the primary modality for initial staging. If pancreatic neoplasm is suspected, either clinically or as a consequence of prior investigation including ultrasound and / or tumour markers, a dedicated staging CT should be performed. If pancreatic neoplasm is detected / suspected on CT undertaken as a survey abdominal scan, a recall for dedicated CT is often not essential CT scan protocol CT of the thorax, abdomen and pelvis is performed. This should be ideally done without prior stenting of bile ducts which may preclude accurate staging. Oral administration of 1 litre of water as a contrast agent ml of intravenous iodinated contrast medium injected at 3-4ml/sec. MDCT is commenced at 35-40sec (pancreatic phase) and 60-80seconds (portal venous phase). Slice thickness are acquired at mm in the pancreatic phase and 2mm in the portal venous phase. Although CT of chest is not considered essential, this may be necessary for patients with unresectable cancers undergoing chemotherapy or who can be enrolled in a study. CT scan of the chest can be performed at 20-25sec as part of the initial staging scan or can be performed separately if considered necessary (in the latter case a non-contrast study may be sufficient) Endoscopic ultrasound All patients considered fit for surgery and without metastatic disease on CT scan should have endoscopic ultrasound to assess local staging and resectability. This should be ideally done prior to decompression of the biliary system. Endoscopic ultrasound guided biopsy is also considered essential to confirm diagnosis in unresectable tumours. Upper GI CEG Imaging Guidelines Version 1.4 June 2012 Page 7

8 4.1.3 MRI May be useful for problem-solving in patients suspected to have liver metastasis or for further clarification of pancreatico-biliary anatomy. MRI as a primary modality of diagnosis/ staging is not considered to be a good technique at present PET-CT This has not been shown to be value in staging of pancreatic cancer and may be considered in selective cases after discussion at the specialist MDT. 4.2 Follow up CT scan at 3 months following surgery is recommended as a baseline for further assessment. Further follow up imaging is considered only if there is clinical suspicion of recurrence. If there is incomplete resection (R1) and further treatment is planned, then a baseline CT scan prior to commencement of chemotherapy may be useful. If palliative chemotherapy / radiotherapy is considered due to locally advanced or metastatic disease, follow up is performed by CT scan at a frequency corresponding to the chemotherapy regime after MDT decision. 5. Liver Liver metastases is the commonest form of liver disease in the UK. Benign liver lesions are frequently present and it is important to differentiate between benign and malignant lesions. This can be done by ultrasound, contrast ultrasound, CT or MRI. PET-CT can also be used in selective cases. HCC (hepato-cellular carcinomas) is the commonest primary malignant liver tumour although it represents only 1% of all liver tumours. It often occurs in a background of cirrhosis. 5.1 Staging of malignant liver lesions Primary and secondary malignant lesions are staged in a similar manner. The primary modality of staging is by CT scan CT scan protocol CT of the thorax, abdomen and pelvis is performed. Oral administration of 1 litre of water or diluted iodinated contrast medium is used ml of intravenous iodinated contrast medium injected at 3-4ml/sec. MDCT is commenced at 20-25sec (chest) and 60-80seconds (abdomen and pelvis) Slice thickness are acquired at mm. If possible the liver should be imaged at late arterial phase at 30-35sec or as part of the arterial phase imaging of the chest. Page 8 Upper GI CEG Imaging Guidelines Version 1.4 June 2012

9 5.1.2 MRI scan If liver is the only site of metastasis and liver resection or ablative therapy is considered, then further imaging with MRI is essential. This should be performed with Gadolinium based contrast agent. Liver specific contrast agents may also be used to improve detection of lesions PET CT PET-CT if available is considered essential if liver resection is planned to exclude extra-hepatic metastasis. 5.2 Follow up Follow up is done predominantly with CT scan following resection, ablative therapy or chemotherapy. MRI can be considered if lesions are difficult to visualise on CT scan. Follow up is initially at 3 months interval. 6. Gallbladder Gallbladder carcinoma is rare and most are found incidentally following cholecystectomy for benign disease. These tend to be early cancers and if organ confined and no nodal spread may not need further imaging. Gallbladder carcinomas identified by imaging either by ultrasound or CT scan have a propensity to invade adjacent liver and so carry a poor prognosis. 6.1 Staging of gallbladder carcinoma Gallbladder carcinomas are initially staged by CT scan CT scan protocol A similar protocol to staging of malignant liver lesion is followed MRI scan If the tumour is not organ confined and invades the liver with no evidence of distant metastasis and liver resection is considered, then an MRI scan with contrast is considered essential PET-CT If liver resection is considered, then a PET-CT scan is useful to assess for extra-hepatic spread. 6.2 Follow up Incidental organ confined gallbladder tumours without nodal spread do not necessitate follow up. If follow up is considered due to nodal spread or further treatment by chemotherapy, then this is done by CT scan. Upper GI CEG Imaging Guidelines Version 1.4 June 2012 Page 9

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians

More information

Soft Tissue Tumour & Sarcoma Imaging Guidelines 2012

Soft Tissue Tumour & Sarcoma Imaging Guidelines 2012 Soft Tissue Tumour & Sarcoma Imaging Guidelines 2012 Version Control This is a controlled document please destroy all previous versions on receipt of a new version. Date Approved: March 2011 reissued April

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Dr Ian Chau Consultant Medical Oncologist Women's cancers Breast cancer introduction 3 What profession are you in?

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Carcinoma of unknown primary origin (CUP) Faculty of Clinical Radiology www.rcr.ac.uk Contents Carcinoma of

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected

More information

PANCREATIC CANCER GUIDELINES

PANCREATIC CANCER GUIDELINES PANCREATIC CANCER GUIDELINES North-East London Cancer Network & Barts and the London HPB Centre PROTOCOL FOR MANAGEMENT OF PANCREATIC CANCER (SEPTEMBER 2010) I. PRE-REFERRAL GUIDELINES Screening 1. Offer

More information

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic cancer Section AA Cancer Centre Referrals In the absence of metastatic

More information

IMAGING GUIDELINES - COLORECTAL CANCER

IMAGING GUIDELINES - COLORECTAL CANCER IMAGING GUIDELINES - COLORECTAL CANCER DIAGNOSIS The majority of colorectal cancers are diagnosed on colonoscopy, with some being diagnosed on Ba enema, ultrasound or CT. STAGING CT chest, abdomen and

More information

Management of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES

Management of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES London Cancer Hepatic Pancreatic and Biliary (HPB) Faculty Management of Patients with Suspected Cholangiocarcinoma CLINICAL GUIDELINES JULY 2014 This operational policy is agreed and accepted by: Designated

More information

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Date: April 2015 Date for review: April 2018 1. Principles The recognised specialist HPB MDT for Greater

More information

Upper Gastro-Intestinal (UGI) and Hepato-Pancreato Biliary (HPB) Cancer Network Site Specific Group. Clinical Guidelines.

Upper Gastro-Intestinal (UGI) and Hepato-Pancreato Biliary (HPB) Cancer Network Site Specific Group. Clinical Guidelines. Upper Gastro-Intestinal (UGI) and Hepato-Pancreato Biliary (HPB) Cancer Network Site Specific Group June 2015 Revision due: April 2016 Page 1 of 40 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT. PLEASE

More information

Guideline for the Management of Vulval Cancer

Guideline for the Management of Vulval Cancer Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11

More information

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Cancer of Unknown Primary Network Site Specific Group Revision due: April 2019 Page 1 of 11 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT.

More information

Protocol for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat: UPPER GI CANCER

Protocol for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat: UPPER GI CANCER Protocol for Planning and Treatment The process to be followed when a course of chemotherapy is required to treat: UPPER GI CANCER Patient information given at each stage following agreed information pathway

More information

Oesophagogastric Cancer The Patient s Pathway

Oesophagogastric Cancer The Patient s Pathway National helpline: 0121 704 9860 V1 Oesophagogastric Cancer The Patient s Pathway {Based on The St Thomas Hospital Pathway} Registered Charity No. 1062461 Contents Introduction 3-5 Curative pathway 5-7

More information

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts) Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones

More information

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which

More information

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound EFSUMB Newsletter 87 Examinations should encompass the full range of pathological conditions listed below A log book listing the types of examinations undertaken should be kept Training should usually

More information

Hepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK)

Hepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Hepato-Pancreatico-Biliary Surgery Dr. Ankur J. Shah MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Consultant Hepato-Pancreatico-Biliary and Liver Transplant Surgeon Ansh Liver Clinic Prevention to Cure Address

More information

National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia

National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia Patient Details Surname: NHS number: Forename: Postcode: Sex: Male Female

More information

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5 Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5 Contents 5. Assessment & Management of Liver Metastases 42 5.1. Metachronous

More information

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83 Oesophago-gastric cancer: assessment and management in adults NICE guideline Published: 24 January 18 nice.org.uk/guidance/ng83 NICE 18. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Appendix 9: Endoscopic Ultrasound in Gastroenterology

Appendix 9: Endoscopic Ultrasound in Gastroenterology Appendix 9: Endoscopic Ultrasound in Gastroenterology This curriculum is intended for clinicians who perform endoscopic ultrasonography (EUS) in gastroenterology. It includes standards for theoretical

More information

Bladder Cancer Guidelines

Bladder Cancer Guidelines Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder

More information

Together, putting patients first

Together, putting patients first The Role of a Gastroenterologist in the Diagnosis and Management of Pancreatic Cancer Sarah Jowett, Consultant Gastroenterologist Bradford Teaching Hospitals Trust Leeds Regional Study Day, 12 September

More information

SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske

SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske SMALL BOWEL ADENOCARCINOMA Dr. C. Jeske Case presentation 54 year old female. Presents with OJ and weight loss. Abdominal examination only reveals a palpable gallbladder. ERCP reveals a circumferential

More information

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE PROFESSOR OF SURGERY & DIRECTOR, PROFESSIONAL DEVELOPMENT CENTRE J I N N A H S I N D H M E D I C A L U N I V E R S I T Y faisal.siddiqui@jsmu.edu.pk

More information

Liver and Pancreatic Case discussion

Liver and Pancreatic Case discussion The Royal Marsden Liver and Pancreatic Case discussion Dr Ian Chau Consultant Medical Oncologist The Royal Marsden 77 year old gentleman with 2 months history of vague abdominal ache and clinically finding

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Intraoperative staging of GIT cancer using Intraoperative Ultrasound

Intraoperative staging of GIT cancer using Intraoperative Ultrasound Intraoperative staging of GIT cancer using Intraoperative Ultrasound Thesis For Fulfillment of MSc Degree In Surgical Oncology By Abdelhalim Salah Abdelhalim Moursi M.B.B.Ch (Cairo University ) Supervisors

More information

Pancreas Case Scenario #1

Pancreas Case Scenario #1 Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass

More information

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer Locoregional (N stage) disease was redefined in the seventh edition of the AJCC Cancer Staging Manual as any periesophageal lymph

More information

National Breast Cancer Audit next steps. Martin Lee

National Breast Cancer Audit next steps. Martin Lee National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Renal and adrenal tumours Faculty of Clinical Radiology www.rcr.ac.uk Contents Renal cell carcinoma 3 Clinical

More information

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015 Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015 1 Contents Page No. 1. Objective 3 2. Imaging Techniques 3 3. Staging of Colorectal Cancer 5 4. Radiological Reporting 6

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

CHOLANGIOCARCINOMA (CCA)

CHOLANGIOCARCINOMA (CCA) CHOLANGIOCARCINOMA (CCA) Deepak Hariharan MD (Research), FRCS, Locum Consultant HPB Surgeon AIM Outline essential facts & principles Present 4 cases Discuss Challenges /Controversies INTRODUCTION Most

More information

Esophageal Cancer. What is esophageal cancer?

Esophageal Cancer. What is esophageal cancer? Scan for mobile link. Esophageal Cancer Esophageal cancer occurs when cancer cells develop in the esophagus. The two main types are squamous cell carcinoma and adenocarcinoma. Esophageal cancer may not

More information

Cholangiocellular carcinoma. Dr. med. Henrik Csaba Horváth PhD

Cholangiocellular carcinoma. Dr. med. Henrik Csaba Horváth PhD Cholangiocellular carcinoma Dr. med. Henrik Csaba Horváth PhD Acalculous biliary diseases April 12, 2017 2 Cholangiocarcinoma A slow growing malignancy of the biliary tract which tend - to infiltrate locally

More information

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt of a new version. Date

More information

Pancreatic Cancer. What is pancreatic cancer?

Pancreatic Cancer. What is pancreatic cancer? Scan for mobile link. Pancreatic Cancer Pancreatic cancer is a tumor of the pancreas, an organ that is located behind the stomach in the abdomen. Pancreatic cancer does not always cause symptoms until

More information

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R 2 0 1 2 Objectives Discuss Diagnostic and staging strategies in oncology Know

More information

Esophageal Cancer. Source: National Cancer Institute

Esophageal Cancer. Source: National Cancer Institute Esophageal Cancer Esophageal cancer forms in the tissues that line the esophagus, or the long, hollow tube that connects the mouth and stomach. Food and drink pass through the esophagus to be digested.

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options: HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,

More information

3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI

3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI Overview Postgraduate Course in General Surgery Case presentation Differential diagnosis Diagnosis and therapy Outcomes Principles of palliative care Eric K. Nakakura Ko Olina, HI March 27, 2012 CASE 1:

More information

Jose Ramos. Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma

Jose Ramos. Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma Role of Surgery in isolated hepatic metastasis from breast carcinoma, melanoma or sarcoma Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre Evolution of liver resection Better understanding

More information

A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY

A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY St. Peter s Hospital Advanced Endoscopy & Hepatobiliary Center Welcome The St. Peter s Hospital Advanced Endoscopy & Hepatobiliary Center is a leader

More information

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.

More information

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer Ovarian cancer Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru Suitable candidates for neo-adjuvant

More information

Case Scenario 1. Discharge Summary

Case Scenario 1. Discharge Summary Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal

More information

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department

More information

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging Saturday, November 5, 2005 8:30-10:30 a. m. Poorly Differentiated Endocrine Carcinomas Chairman: E. Van Cutsem, Leuven, Belgium 9:00-9:30 a. m. Working Group Sessions Pathology and Genetics Group leaders:

More information

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Liver Tumors. Prof. Dr. Ahmed El - Samongy Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma

More information

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor

More information

Cancer of Unknown Primary (CUP)

Cancer of Unknown Primary (CUP) Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and

More information

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW Gastric Cancer Staging AJCC eighth edition Duncan McLeod Westmead Hospital, NSW Summary of changes New clinical stage prognostic groups, ctnm Postneoadjuvant therapy pathologic stage groupings, yptnm -

More information

Evaluation of Suspected Pancreatic Cancer

Evaluation of Suspected Pancreatic Cancer Evaluation of Suspected Pancreatic Cancer October 15, 2015 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-779-3239 Toll

More information

COLORECTAL CANCER STAGING in 2010

COLORECTAL CANCER STAGING in 2010 COLORECTAL CANCER STAGING in 2010 Robert A. Halvorsen, MD, FACR MCV Hospitals / VCU Medical Center Richmond, Virginia I do not have any relevant financial relationships with any commercial interests COLON

More information

Clinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network

Clinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network Gynaecological Cancer Managed Clinical Network Audit Report Ovarian Cancer Quality Performance Indicators Cervical Cancer Quality Performance Indicators Endometrial Cancer Quality Performance Indicators

More information

Navigators Lead the Way

Navigators Lead the Way RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and

More information

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System SGNA: Back to Basics Rogelio G. Silva, MD Assistant Clinical Professor of Medicine University of Illinois at Chicago Department of Medicine Division of Gastroenterology Advocate Christ Medical Center GI

More information

Upper GI Cancer Quality Performance Indicators

Upper GI Cancer Quality Performance Indicators Publication Report Upper GI Cancer Quality Performance Indicators Patients diagnosed during January 2013 to December 2015 Publication date 28 th March 2017 An Official Statistics Publication for Scotland

More information

OESOPHAGO-GASTRIC CANCER 2016

OESOPHAGO-GASTRIC CANCER 2016 SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT OESOPHAGO-GASTRIC CANCER 2016 COMPARATIVE AUDIT REPORT Mr Peter Lamb SCAN Lead Upper GI Cancer Clinician Dr Jonathan Fletcher, Consultant Physician,

More information

5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis

5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis Overview Case presentation Postgraduate Course in General Surgery Differential diagnosis Diagnosis and therapy Eric K. Nakakura Koloa, HI March 26, 2013 Outcomes CASE 1: CASE 1: A 78-year-old man developed

More information

Surgical. Gastroenterology. Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies

Surgical. Gastroenterology. Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Tropical Gastroenterology 2010;31(3):190 194 Surgical Gastroenterology Evaluating the efficacy of tumor markers and CEA to predict operability and survival in pancreatic malignancies Jay Mehta, Ramkrishna

More information

Afternoon Session Cases

Afternoon Session Cases Afternoon Session Cases Case 1 19 year old woman Presented with abdominal pain to community hospital Mild incr WBC a14, 000, Hg normal, lipase 100 (normal to 75) US 5.2 x 3.7 x 4 cm mass in porta hepatis

More information

National Optimal Lung Cancer Pathway

National Optimal Lung Cancer Pathway National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August

More information

Evidence tabel stadiering

Evidence tabel stadiering Evidence tabel stadiering Auteurs, T stage Syst Reviews Kwee, 2007 Systematic review Studies included up to aug 2006 Kelly, 2001 Systematic review Studies included from 1991-1996 steekproefgrootte) Included

More information

MDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH

MDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH MDT IMPROVEMENT PROJECT Professor Muntzer Mughal, UCLH 1995..assessment and management of rare cancers in multidisciplinary teams.. 2000 the care of all patients with cancer should be formally reviewed

More information

Management of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital

Management of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital Management of Cholangiocarcinoma Roseanna Lee, MD PGY-5 Kings County Hospital Case Presentation 37 year old male from Yemen presented with 2 week history of epigastric pain, anorexia, jaundice and puritis.

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Colorectal cancer: diagnosis and management of colorectal cancer 1.1 Short title Colorectal cancer 2 The remit The Department

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Slide 1. Slide 2. Slide 3 Pancreatic Cancer- Case #1. Endoscopic management of GI malignancy. Endoscopic approaches in GI malignancy- Agenda

Slide 1. Slide 2. Slide 3 Pancreatic Cancer- Case #1. Endoscopic management of GI malignancy. Endoscopic approaches in GI malignancy- Agenda Slide 1 A teaching hospital of Harvard Medical School Endoscopic management of GI malignancy Tyler Berzin MD, MS Center for Advanced Endoscopy Division of Gastroenterology Beth Israel Deaconess Medical

More information

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer [Based on WOSCAN NSCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED

More information

Brain Tumors. What is a brain tumor?

Brain Tumors. What is a brain tumor? Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain

More information

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies

More information

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux. Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately

More information

A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer Harewood G C, Wiersema M J

A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer Harewood G C, Wiersema M J A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer Harewood G C, Wiersema M J Record Status This is a critical abstract of an economic evaluation that meets the criteria for

More information

Imaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD

Imaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD Imaging techniques in the diagnosis, staging and follow up of GI cancers Moderators: Banke Agarwal, MD and Paul Schultz, MD Panelists Axel Grothey, MD Professor of Oncology Division of Medical Oncology

More information

Treatment for cancer of the gall bladder

Treatment for cancer of the gall bladder Treatment for cancer of the gall bladder Hepatobiliary Services Information for Patients Liver i Stomach Pancreas Gall bladder Introduction The aim of this booklet is to help you understand more about

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Malignant melanoma: assessment and management of malignant melanoma 1.1 Short title Malignant Melanoma 2 The remit The Department

More information

COLORECTAL CARCINOMA

COLORECTAL CARCINOMA QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian

More information

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Original Prepared by NMcL April 2016

More information

PANCREAS DUCTAL ADENOCARCINOMA PDAC

PANCREAS DUCTAL ADENOCARCINOMA PDAC CONTENTS PANCREAS DUCTAL ADENOCARCINOMA PDAC I. What is the pancreas? II. III. IV. What is pancreas cancer? What is the epidemiology of Pancreatic Ductal Adenocarcinoma (PDAC)? What are the risk factors

More information

Hepatobiliary and Pancreatic Malignancies

Hepatobiliary and Pancreatic Malignancies Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre

More information

Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

EFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community

EFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community MINIMUM TRAINING REQUIREMENTS FOR THE PRACTICE OF MEDICAL ULTRASOUND IN EUROPE Appendix 9: Endoscopic Ultrasound in Gastroenterology This curriculum is intended for clinicians who perform endoscopic ultrasonography

More information

GUIDELINES FOR CANCER IMAGING Lung Cancer

GUIDELINES FOR CANCER IMAGING Lung Cancer GUIDELINES FOR CANCER IMAGING Lung Cancer Greater Manchester and Cheshire Cancer Network Cancer Imaging Cross-Cutting Group April 2010 1 INTRODUCTION This document is intended as a ready reference for

More information

Faster Cancer Treatment Indicators: Use cases

Faster Cancer Treatment Indicators: Use cases Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:

More information

Multiple Primary Quiz

Multiple Primary Quiz Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY COLORECTAL CLINICAL SUBGROUP RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY Finalised by: Dr Simon Gollins Mr Andrew Renehan Dr Mark Saunders Mr Nigel Scott Dr Shabbir

More information

Biliary tree dilation - and now what?

Biliary tree dilation - and now what? Biliary tree dilation - and now what? Poster No.: C-1767 Congress: ECR 2012 Type: Educational Exhibit Authors: I. Ferreira, A. B. Ramos, S. Magalhães, M. Certo; Porto/PT Keywords: Pathology, Diagnostic

More information

GASTROINTESTINAL MALIGNANCIES

GASTROINTESTINAL MALIGNANCIES Outline GASTROINTESTINAL MALIGNANCIES Bassel F. El-Rayes Winship Cancer Institute Emory University Colorectal Cancer Pancreas Cancer Gastric Cancer Hepatobiliary Cancer Anal Cancer Introduction Epidemiology

More information